Oyster Point Pharma, Inc. Total Assets
Oyster Point Pharma, Inc. had Total Assets of $109.20 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2022-11-10
- 2022-09-30: Assets $109.20M.
- 2022-06-30: Assets $143.94M.
- 2022-03-31: Assets $176.72M.
- 2021-12-31: Assets $222.62M.
| Period end | Assets |
|---|---|
| 2022-09-30 | $109.20M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $143.94M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $176.72M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $222.62M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $195.01M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $161.50M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $184.77M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $197.91M 10-K · filed 2022-02-24 |
| 2020-09-30 | $216.50M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $229.98M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $132.31M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $143.21M 10-K · filed 2021-02-18 |
| 2019-09-30 | $80.08M 10-Q · filed 2019-12-03 |
| 2018-12-31 | $5.70M 10-K · filed 2020-02-27 |